Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research
In February 2020, we announced that Certara’s discovery research relationship with Arvinas had expanded to include a greater diversity of small molecule drug discovery projects and data sources. In 2017, Arvinas switched over to D360 from their former, legacy informatics reporting system. Their growing informatics needs were not being met by their legacy system. They wanted to easily view and manipulate data into tables, conduct SAR analysis, and have options for form and spreadsheet views, all within their informatics platform. After seeing D360’s capabilities, the Arvinas team knew that it would meet their current and ongoing needs, and they selected to move forward with D360 and recently expanded their use of D360.
We need to be able to query, pivot and dive deep into our drug discovery data, and D360 is the best platform we have found for that. Compared to our previous research informatics solution, D360 is saving us hundreds of hours annually on data analysis. That is an important contribution to our research. The Certara team is tenacious and resourceful. They always find a solution. That’s what has made our relationship so successful.